Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Nkarta Inc

NKTX
2,53
0,24 (10,48%)
14 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/12/202412:01GLOBENkarta Announces IND Clearance of Investigator-Sponsored..
26/11/202413:02GLOBENkarta to Participate in an Upcoming Investor Conference
14/11/202422:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:02GLOBENkarta to Participate in an Upcoming Investor Conference
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202422:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:11EDGAR2Form 8-K - Current report
07/11/202422:02GLOBENkarta Reports Third Quarter 2024 Financial Results and..
26/10/202403:44EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
03/9/202422:01GLOBENkarta to Participate in Upcoming Investor Conference
23/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202403:03GLOBECorrection: Nkarta Reports Second Quarter 2024 Financial..
13/8/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:05EDGAR2Form 8-K - Current report
13/8/202422:01GLOBENkarta Reports Second Quarter 2024 Financial Results and..
31/7/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/7/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202412:00GLOBENkarta Announces Initiation of Investigator-Sponsored..
16/7/202412:30EDGAR2Form 8-K - Current report
16/7/202412:01GLOBENkarta Announces Leadership Updates, Appoints Nadir Mahmood..
27/6/202412:00GLOBENkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis..
14/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/6/202422:22EDGAR2Form 8-K - Current report
13/6/202422:01GLOBENkarta Adds Experienced Leader in Autoimmune R&D, George..
09/5/202422:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:04EDGAR2Form 8-K - Current report
09/5/202422:01GLOBENkarta Reports First Quarter 2024 Financial Results and..
03/4/202422:02GLOBENkarta to Participate in Upcoming Investor Conferences
25/3/202411:30GLOBENkarta Announces Pricing of $240 Million Underwritten..
21/3/202421:01GLOBENkarta Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:32EDGAR2Form 144 - Report of proposed sale of securities
28/2/202414:01GLOBENkarta to Participate in Upcoming Investor Conferences
15/2/202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:20EDGAR2Form 144 - Report of proposed sale of securities
09/2/202412:38EDGAR2Form SC 13D/A - General statement of acquisition of..
18/1/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:50EDGAR2Form 8-K - Current report
03/1/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
Apertura: 2,29 Min: 2,24 Max: 2,44
Chiusura: 2,29

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network